Related Experiment Video
Updated: Jun 26, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Survivin as a Therapeutic Target for the Treatment of Human Cancer
1Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Abstract:
Survivin was initially identified as a member of the inhibitor apoptosis (IAP) protein family and has been shown to play a critical role in the regulation of apoptosis. More recent studies showed that survivin is a component of the chromosome passenger complex and acts as an essential mediator of mitotic progression. Other potential functions of survivin, such as mitochondrial function and autophagy, have also been proposed. Survivin has emerged as an attractive target for cancer therapy because its overexpression has been found in most human cancers and is frequently associated with chemotherapy resistance, recurrence, and poor survival rates in cancer patients. In this review, we discuss our current understanding of how survivin mediates various aspects of malignant transformation and drug resistance, as well as the efforts that have been made to develop therapeutics targeting survivin for the treatment of cancer.
Insights
Survivin, a protein regulating cell death and mitosis, is overexpressed in cancers, driving tumor growth and drug resistance. Targeting survivin offers a promising strategy for developing novel cancer therapeutics.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Survivin, an inhibitor of apoptosis (IAP) protein, regulates apoptosis and mitotic progression.
- It functions as a component of the chromosome passenger complex.
- Emerging roles in mitochondrial function and autophagy are also proposed.
Purpose of the Study:
- To review the multifaceted roles of survivin in cancer.
- To discuss survivin's involvement in malignant transformation and drug resistance.
- To summarize therapeutic strategies targeting survivin for cancer treatment.
Main Methods:
- Literature review of survivin's functions and therapeutic targeting.
- Analysis of survivin's role in apoptosis, mitosis, and cancer progression.
- Evaluation of survivin-targeted drug development efforts.
Main Results:
- Survivin overexpression is common in human cancers.
- It correlates with chemotherapy resistance, recurrence, and poor patient survival.
- Survivin's diverse functions contribute to malignant transformation.
Conclusions:
- Survivin is a critical mediator of cancer development and progression.
- Targeting survivin presents a viable therapeutic avenue for various cancers.
- Further research into survivin-targeted therapies is warranted.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

